Pinghua Lei, Jie Zhu, and Chiung Ying "Joann" Chen v. Natural Polymer International Corporation and NPIC Shanghai Co., LTD.

578 S.W.3d 706
Court of Appeals of Texas·Decided June 21, 2019·No. 05-18-01041-CV·Published·Cited by 22 cases

Opinion

AFFIRM; and Opinion Filed June 21, 2019.

In The Court of Appeals Fifth District of Texas at Dallas No. 05-18-01041-CV

PINGHUA LEI, JIE ZHU, AND CHIUNG YING “JOANN” CHEN, Appellants V. NATURAL POLYMER INTERNATIONAL CORPORATION AND NPIC SHANGHAI CO., LTD., Appellees

On Appeal from the 199th Judicial District Court Collin County, Texas Trial Court Cause No. 199-01725-2018

OPINION Before Justices Myers, Osborne, and Nowell Opinion by Justice Osborne Appellants Pinghua Lei, Jie Zhu, and Chiung Ying “Joann” Chen appeal the trial court’s

order denying their motion to dismiss under the Texas Citizens Participation Act. TEX. CIV. PRAC.

& REM. CODE § 27.001–.011 (“TCPA”). They also appeal the trial court’s award of attorney’s fees

and court costs to appellees Natural Polymer International Corporation and NPIC Shanghai Co.,

Ltd. (together, “NPIC”),1 based on a finding that the motion to dismiss was frivolous. Id.

§ 27.009(b). We affirm the trial court’s order.

1 Appellants assert one argument that applies only to NPIC Shanghai, regarding NPIC Shanghai’s “abandonment” of some of its claims. Given our resolution of appellants’ first issue, we need not address this contention. Consequently, our references to “NPIC” include both appellees. BACKGROUND

NPIC manufactures and distributes natural pet treat products. Lei, Zhu, and Chen are

former employees of NPIC who now work for Gambol USA, NPIC’s direct competitor in the

North American pet treat market. At the time they left NPIC, Zhu was NPIC’s Research and

Development Director, Lei was a Research and Development Food Scientist, and Chen was a

Quality Control Manager.

In its operative petition, NPIC pleaded that:

 Its business is “highly competitive”;

 Its expertise in developing the formulas, manufacturing specifications, and manufacturing processes necessary to make its products “has taken many years to develop and fine-tune”;

 Lei, Zhu, and Chen “were granted access to highly confidential trade secrets by virtue of their respective positions at NPIC”;

 Gambol USA, where Lei, Zhu, and Chen are now employed, is a direct competitor of NPIC in the North American pet treat market;

 Gambol USA is a new wholly-owned subsidiary of Gambol China, “already a major force in the pet treat market in China and other markets,” and Lei, Zhu, and Chen have joined Gambol USA “in an apparent attempt to jump start the new competitor using NPIC’s trade secrets and confidential information”; and

 Lei and Zhu took NPIC’s trade secrets and confidential information with them and provided it to Gambol USA, in violation of their non-disclosure and non- competition agreements with NPIC.

NPIC also pleaded that it is “one of a select few in its industry that has successfully

managed to mass produce and market natural pet treats using injection molding,” which has

enabled it “to develop some of the premier brands in the natural pet products industry.” It has

developed a four-step design and manufacturing process involving “trade secrets that give NPIC a

competitive advantage and are valuable to a competitor,” including (1) raw materials used;

(2) sourcing of high quality raw materials; (3) precise measurements for each formula ingredient;

(4) mixing technique and timing for mixing the formula ingredients; (5) heating temperatures and

–2– times; (6) precise injection molding specifications; and (7) drying temperatures and times. NPIC

“enforces stringent quality control measures” for its design and manufacturing process. NPIC

alleged that its specifications for the extrusion and soft treat manufacturing process constitute trade

secrets “that NPIC expends significant resources to develop, document, and protect.” NPIC further

alleged that it “expends significant resources to develop, document, and protect trade secrets

pertinent to the robotic automation of its manufacturing processes and its extensive food safety

and quality control measures.” NPIC also pleaded that it has developed and documented trade

secrets “pertinent to the processes and procedures it has implemented in its efforts to obtain SQF

Level 3 certification, the highest food safety and quality control certification in the industry issued

by the Safe Quality Food Institute.”

Because their positions with NPIC required access to some or all of NPIC’s trade secrets

to properly fulfill their job duties, NPIC required Lei, Zhu, and Chen to sign a noncompetition

agreement and a nondisclosure agreement. Zhu signed the agreements in 2008, Chen in 2010, and

Lei in 2011. The nondisclosure agreement required Lei, Zhu, and Chen to refrain from disclosing

or using NPIC’s proprietary information as defined in the agreement.

Lei, Zhu, and Chen resigned from NPIC in October and November of 2017 and took

positions with Gambol USA. Lei is Gambol USA’s Research and Development Manager/Senior

Scientist, Zhu is Gambol USA’s Chief Operating and Technology Officer, and Chen is a “QC

manager.” NPIC has pleaded that Zhu and Lei “transferred massive amounts of NPIC information,

including NPIC’s entire R&D folder maintained on its password-protected network drive, to their

own electronic storage devices just prior to leaving NPIC,” plugged these electronic storage

devices into their Gambol USA-issued laptops and transferred the information, and also transferred

the information to other electronic storage devices. The R&D folder “contains voluminous

amounts of highly confidential and valuable” trade secrets.

–3– NPIC alleged causes of action for breach of contract against Zhu, Lei, and Chen, and causes

of action for misappropriation of trade secrets, unfair competition by misappropriation, breach of

fiduciary duty, and conversion against Zhu and Lei. NPIC pleaded for actual damages and

equitable relief.

Zhu, Lei, and Chen filed a motion to dismiss under the TCPA, asserting that NPIC’s claims

were based on, related to, or in response to a list of ten “TCPA-protected ‘communications’”:

1. The noncompetition and nondisclosure agreements between NPIC and appellants;

2. Appellants’ signatures on those agreements;

3. Communications between and among appellants and Gambol USA;

4. Zhu’s “confirm[ation] in his deposition that he reports directly to Gambol China’s

CEO”;

5. Zhu’s alleged “regular correspond[ence] with [Gambol China’s CEO]”;

6. Zhu’s and Lei’s transfer of NPIC information to electronic storage devices;

7. Zhu’s and Lei’s deletion of “massive amounts of NPIC information”;

8. Zhu’s and Lei’s creation and subsequent transfer of duplicated copies of NPIC

information;

9. Zhu’s and Lei’s disclosure of misappropriated trade secret information to Gambol

USA and Gambol China; and

10. Zhu’s and Lei’s disclosure of NPIC’s trade secrets to Gambol.

Appellants argued that NPIC’s claims were based on or related to their exercise of the

right of free speech, the right of association, and the right to petition. They contended that NPIC’s

claims were based on their right of free speech because the communications were made in

connection with a matter of public concern, specifically a good, product, or service in the

marketplace. Further, they contended that “because all of these communications relate to the dog

–4– treats, they all relate to ‘health or safety’ and ‘community well-being’ as well.” Regarding the right

to petition, appellants argued their “statements during their depositions in this case” were

Free access — add to your briefcase to read the full text and ask questions with AI

Pinghua Lei, Jie Zhu, and Chiung Ying "Joann" Chen v. Natural Polymer International Corporation and NPIC Shanghai Co., LTD., 578 S.W.3d 706 (Tex. Ct. App. 2019).

578 S.W.3d 706 (Pinghua Lei, Jie Zhu, and Chiung Ying "Joann" Chen v. Natural Polymer International Corporation and NPIC Shanghai Co., LTD.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

DaSean A. Jones v. Tami C. Pierce
Court of Appeals of Texas, 2023
Michael A. Ruff v. Suzann Ruff
Court of Appeals of Texas, 2022
Richard Goldberg v. EMR (USA Holdings) Inc.
Court of Appeals of Texas, 2020